NCT01661738View on ClinicalTrials.gov

Clinical Trial of Group ACYW135 Meningococcal Polysaccharide Vaccine 002

PHASE2CompletedINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

May 31, 2006

Study Completion Date

June 30, 2006

Conditions
Meningitis
Interventions
BIOLOGICAL

Group ACYW135 Meningococcal Polysaccharide Vaccine

360 subjects were divided into three groups (120 subjects in each group), children (2\~6 years of age), early youth (7\~15 years of age) and adult (16\~30 years of age) to receive Group ACYW135 Meningococcal Polysaccharide Vaccine, 0.5 ml, one dose regime

Sponsors
All Listed Sponsors
lead

Hualan Biological Engineering, Inc.

INDUSTRY